The group’s principal activities include discovering, developing and commercializing vaccines and immune system. The group products sold under the trade names Iomai(R), Transcutaneous Immunization(TM), TCI(TM) and Skin Deep(TM). The group operates from the United States. The revenue of the group for the year 2006 was $1,475 (thousands).
